Alterome Therapeutics
Latest round
- Series B
Last raised
- Apr 2024
Total raised
- $231M
Investors
- 11
About Alterome Therapeutics
Based in California, US, and founded in 2019, Alterome Therapeutics, Inc. is a biopharmaceutical company developing alteration-specific targeted therapies for the treatment of cancer. Eric Murphy is the CEO of the company. In April 2024, Alterome Therapeutics, Inc.65 million post-money. The firm develops alteration-specific therapeutics to address high-value and validated oncogenic drivers, providing the healthcare industry with better therapies for the treatment of cancer.
Who invested in Alterome Therapeutics
11 investors across 3 rounds
See all investors in Alterome Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alterome Therapeutics
Who invested in Alterome Therapeutics?
Alterome Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alterome Therapeutics raised?
Alterome Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Alterome Therapeutics last raise money?
Alterome Therapeutics's most recent round on record is a Series B, in Apr 2024.
What does Alterome Therapeutics do?
Based in California, US, and founded in 2019, Alterome Therapeutics, Inc.
Where is Alterome Therapeutics headquartered?
Alterome Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Alterome Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alterome Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alterome Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.